Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy

NCT00780910 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

109

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: MP-424
DRUG: Ribavirin
DRUG: Peginterferon Alfa-2b

Sponsor

Tanabe Pharma Corporation

Collaborators

[object Object]